Alexion Pharmaceuticals, Inc.

Corporate group: AstraZeneca Group

Total cases

14 (7 active)

Claimant-side

Respondent-side

Alexion Pharmaceuticals, Inc. has been party to 14 Unified Patent Court cases, 4 times as claimant and 10 times as respondent. The most recent on record is UPC CoA 750/2025 at the Court of Appeal, brought by Samsung Bioepis NL B.V.

Adversary analytics require an account

Recent cases

View all cases

2025-08-14UPC CoA 750/2025Court of Appeal—Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
2025-08-13UPC CoA 744/2025Court of AppealWithdrawnSamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
2025-07-22UPC CFI 674/2025Hamburg LD—Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
2025-01-23UPC CFI 51/2025Hamburg LD—Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
2025-01-22UPC CFI 40/2025Hamburg LDCosts onlySamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
2025-01-21UPC APP 3053/2025Hamburg LD—Amgen GmbH v Alexion Pharmaceuticals, Inc.
2024-11-08UPC APP 60271/2024Hamburg LD—Name not displayed for GDPR reasons. Represented by Jochen HÖHFELD v Alexion Pharmaceuticals, Inc.
2024-10-31UPC CFI 642/2024Milan CD—AMGEN Switzerland AG Vilniaus filialas v Alexion Pharmaceuticals, Inc.
2024-07-29UPC APP 43687/2024Hamburg LD—Amgen Technology (Ireland) Unlimited Company v Alexion Pharmaceuticals, Inc.
2024-07-26UPC APP 43786/2024Hamburg LDCosts onlySamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.